Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 271 of 6351
-
New drug combo shows promise for rare blood disorder
Disease control OngoingBackground: * Severe aplastic anemia is a rare and serious blood disorder. It happens when the immune system starts to attack the bone marrow cells. This causes the bone marrow to stop making red blood cells, platelets, and white blood cells. Standard treatment for this disease …
Phase 1/2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could an early measles vaccine slash child deaths? trial tests the idea
Prevention CompletedBackground: All observational studies and a few randomised controlled trials (RCT) suggest that early measles vaccine (MV), in particular an early two-dose strategy, has a much better effect on overall mortality than later MV. These results suggest that MV has a non-measles relat…
Phase 4 • Sponsor: Bandim Health Project • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Blood test could replace risky amniocentesis for down syndrome diagnosis
Diagnosis CompletedThe objective of this project is to develop a non-invasive prenatal diagnostic test for trisomy 21 which is reliable, sensitive and cost-effective, and thus, offers an alternative to the currently employed invasive diagnostic tests amniocentesis and chorionic villus sampling. Cu…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
Islet transplants show promise in stopping dangerous blood sugar crashes
Disease control CompletedType 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells are destroyed, resulting in poor blood sugar control. The purpose of this study is to determine the safety and effectiveness of islet transplantation, combined with immunosuppressive med…
Phase 3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a drug duo outsmart EGFR-Mutant lung cancer?
Disease control CompletedRationale: Advanced non-small-cell lung cancer (NSCLC) patients harbouring epidermal growth factor receptor (EGFR) mutations (del19 or L858R) show an impressive progression-free survival between 9 and 14 months when treated with erlotinib. However, the presence of EGFR mutations…
Phase 2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug ibrutinib shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis is a Phase II, single institution open-label, non-randomized monotherapy study to evaluate the clinical efficacy and durable disease control of PCI-32765 administered to patients with relapsed/refractory CLL/SLL/PLL of all risk categories with patients having deletion 17p13 …
Phase 2 • Sponsor: Kami Maddocks, MD • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could donor islet cells free brittle diabetics from insulin shots?
Disease control Recruiting nowThe purpose of this study is to learn about the safety of islet transplantation for Type 1 diabetes mellitus, which may provide more normal control of blood sugar without the need for insulin shots. Islets are special clusters of cells within the pancreas that produce insulin. Th…
Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Less invasive heart valve replacement matches surgery in large trial
Disease control OngoingThe purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgical Aortic Valve Replacement (SAVR) …
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Engineered T-Cells take on childhood leukemia in early trial
Disease control OngoingPatients with relapsed leukemia often develop resistance to chemotherapy. For this reason, we are attempting to use a patient's own T cells, which can be genetically modified to expresses a chimeric antigen receptor(CAR). The CAR enables the T cell to recognize and kill the leuke…
Phase 1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New chemo combo aims to shrink aggressive breast cancer before surgery
Disease control OngoingThis phase II trial studies how well carboplatin and nab-paclitaxel before surgery work in treating patients with triple negative breast cancer that is inflammatory or has spread from where it started to nearby tissue or lymph nodes. Drugs used in chemotherapy, such as carboplati…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New chemo cocktails aim to save eyes in kids with retinoblastoma
Disease control OngoingConservative treatments of retinoblastoma (RETINO 2011) 1. -Multicentric non randomised, phase II study for the patients treated by chemoreduction (VP16, carboplatin) followed by chemothermotherapy without laser treatment at day 8 2. -Multicentric non randomised, phase II study …
Phase 2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hope for older leukemia patients: targeted pill shows promise
Disease control OngoingBackground: \- Chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL) are types of blood or lymph node cancers that mostly affect the elderly. CLL/SLL both create abnormal white blood cells that hurt the immune system and make it more difficult to fight infections…
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a Cancer-Fighting virus shrink tumors when chemo fails?
Disease control CompletedThe purpose of this study is to evaluate the safety, tolerability, and efficacy of JX-594 (Pexa-Vec) administered intravenously either alone or in combination with Irinotecan in colorectal carcinoma patients who are refractory to or intolerant to standard therapy.
Phase 1/2 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a Two-Drug combo quiet early rheumatoid arthritis for good?
Disease control CompletedThis study is intended to evaluate the efficacy and safety of Certolizumab Pegol (CZP) in combination with Methotrexate (MTX) for sustaining clinical response achieved in study RA0055 Period 1 \[NCT01519791\]. Subjects entering this study RA0055 Period 2 achieved sustained Low Di…
Phase 3 • Sponsor: UCB Pharma • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Promising leukemia combo moves to phase 2 trial
Disease control Recruiting nowThis phase II trial studies how well tretinoin and arsenic trioxide with or without gemtuzumab ozogamicin works in treating patients with previously untreated acute promyelocytic leukemia. Drugs used in chemotherapy, such as tretinoin and arsenic trioxide, work in different ways …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a targeted drug slow deadly brain cancer?
Disease control CompletedBKM120 is a newly discovered drug that has been used in other research studies. Information from those other research studies suggests that BKM120 may help to slow or stop the growth of malignant gliomas. The purpose of this study is to see how well BKM120 works in patients with …
Phase 2 • Sponsor: L. Nicolas Gonzalez Castro, MD, PhD • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Heart procedure may beat drugs for AFib patients with heart failure
Disease control CompletedAtrial fibrillation and heart failure are two common heart conditions that are associated with an increase in death and suffering. When both of these two conditions occur in a patient the patient's prognosis is poor. These patients have poor life quality and are frequently admitt…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New Antibody-Drug combo aims to tackle tough leukemia
Disease control Recruiting nowThis phase I/II trial studies the side effects and best dose of inotuzumab ozogamicin and to see how well it works when given together with combination chemotherapy in treating patients with acute lymphoblastic leukemia. Inotuzumab ozogamicin is a monoclonal antibody, called inot…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can a Two-Week hormone course stop epilepsy before it starts?
Prevention Stopped earlyWest syndrome (WS) is a specific type of epilepsy (or seizure disorder) that has three features: infantile spasms (type of seizure), loss of milestones, and a specific pattern on electroencephalogram (EEG or brain wave test) called hypsarhythmia. The purpose of this study is to d…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Prevention
Last updated Sep 10, 2026 03:00 UTC
-
Can a higher radiation dose beat cervical cancer without more harm?
Disease control CompletedThis prospective phase II trial study aims to optimize the increase in dose to the target volume at high risk (85 to 90 Gy over 90% of its volume) and the intermediate target volume (60 Gy to 90 % of its volume) in 3D Pulsed Dose Rate Brachytherapy in treating patients with local…
Phase 2 • Sponsor: Institut de Cancérologie de Lorraine • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC